Ann Lee - 22 Aug 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
22 Aug 2023
Net transactions value
+$3,620
Form type
4
Filing time
05 Mar 2024, 20:00:30 UTC
Previous filing
28 Dec 2022
Next filing
19 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COYA Common Stock, par value $0.0001 per share Purchase $3,620 +1,000 +6.1% $3.62 17,479 22 Aug 2023 By Spouse IRA F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.